Stemline proposes follow-on

Stemline Therapeutics Inc. (NASDAQ:STML), New York, N.Y. Business: Cancer Date announced: 10/17/13 Type: Follow-on To be raised: Up to $90 million Shares: TBD Price prior: $37.99 Underwriters: JPMorga...